Results Show Superior Safety & Efficacy for NRX-101; Accelerated FDA Approval sought for Bipolar Depression: NASDAQ NRXP
NRx Pharmaceuticals Reports Promising Results: Akathisia Reduction and Accelerated Approval Plans : NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) WILMINGTON, DELAWARE, UNITED STATES , May 6, 2024 /EINPresswire.com …